These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Genetically engineered Newcastle disease virus expressing interleukin-2 and TNF-related apoptosis-inducing ligand for cancer therapy. Bai FL; Yu YH; Tian H; Ren GP; Wang H; Zhou B; Han XH; Yu QZ; Li DS Cancer Biol Ther; 2014 Sep; 15(9):1226-38. PubMed ID: 24971746 [TBL] [Abstract][Full Text] [Related]
4. Induction of costimulation of human CD4 T cells by tumor necrosis factor-related apoptosis-inducing ligand: possible role in T cell activation in systemic lupus erythematosus. Tsai HF; Lai JJ; Chou AH; Wang TF; Wu CS; Hsu PN Arthritis Rheum; 2004 Feb; 50(2):629-39. PubMed ID: 14872508 [TBL] [Abstract][Full Text] [Related]
5. IFNgamma sensitization to TRAIL-induced apoptosis in human thyroid carcinoma cells by upregulating Bak expression. Wang SH; Mezosi E; Wolf JM; Cao Z; Utsugi S; Gauger PG; Doherty GM; Baker JR Oncogene; 2004 Jan; 23(4):928-35. PubMed ID: 14647456 [TBL] [Abstract][Full Text] [Related]
6. pIL6-TRAIL-engineered umbilical cord mesenchymal/stromal stem cells are highly cytotoxic for myeloma cells both in vitro and in vivo. Cafforio P; Viggiano L; Mannavola F; Pellè E; Caporusso C; Maiorano E; Felici C; Silvestris F Stem Cell Res Ther; 2017 Sep; 8(1):206. PubMed ID: 28962646 [TBL] [Abstract][Full Text] [Related]
7. Claudin-7 suppresses the cytotoxicity of TRAIL-expressing mesenchymal stem cells in H460 human non-small cell lung cancer cells. Xia P; Wang W; Bai Y Apoptosis; 2014 Mar; 19(3):491-505. PubMed ID: 24242915 [TBL] [Abstract][Full Text] [Related]
8. Tunicamycin sensitizes human melanoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by up-regulation of TRAIL-R2 via the unfolded protein response. Jiang CC; Chen LH; Gillespie S; Kiejda KA; Mhaidat N; Wang YF; Thorne R; Zhang XD; Hersey P Cancer Res; 2007 Jun; 67(12):5880-8. PubMed ID: 17575157 [TBL] [Abstract][Full Text] [Related]
9. Adipose‑derived mesenchymal stem cell‑facilitated TRAIL expression in melanoma treatment in vitro. Jing HX; Duan de J; Zhou H; Hu QM; Lei TC Mol Med Rep; 2016 Jul; 14(1):195-201. PubMed ID: 27177242 [TBL] [Abstract][Full Text] [Related]
10. Combination of gamma-interferon with TRAIL and cisplatin or etoposide induces apoptosis in human neuroblastoma cell line SH-SY5Y. Tong HX; Lu CW; Zhang JH; Ma L; Zhang JH Chin Med Sci J; 2007 Mar; 22(1):38-43. PubMed ID: 17441316 [TBL] [Abstract][Full Text] [Related]
11. IFNgamma sensitizes for apoptosis by upregulating caspase-8 expression through the Stat1 pathway. Fulda S; Debatin KM Oncogene; 2002 Apr; 21(15):2295-308. PubMed ID: 11948413 [TBL] [Abstract][Full Text] [Related]
12. Efficient melanoma cell killing and reduced melanoma growth in mice by a selective replicating adenovirus armed with tumor necrosis factor-related apoptosis-inducing ligand. Fecker LF; Rückert S; Kurbanov BM; Schmude M; Stockfleth E; Fechner H; Eberle J Hum Gene Ther; 2011 Apr; 22(4):405-17. PubMed ID: 20977303 [TBL] [Abstract][Full Text] [Related]
13. TNF-Related Apoptosis-Inducing Ligand (TRAIL)-Armed Exosomes Deliver Proapoptotic Signals to Tumor Site. Rivoltini L; Chiodoni C; Squarcina P; Tortoreto M; Villa A; Vergani B; Bürdek M; Botti L; Arioli I; Cova A; Mauri G; Vergani E; Bianchi B; Della Mina P; Cantone L; Bollati V; Zaffaroni N; Gianni AM; Colombo MP; Huber V Clin Cancer Res; 2016 Jul; 22(14):3499-512. PubMed ID: 26944067 [TBL] [Abstract][Full Text] [Related]
14. TRAIL suppresses tumor growth in mice by inducing tumor-infiltrating CD4(+)CD25 (+) Treg apoptosis. Diao Z; Shi J; Zhu J; Yuan H; Ru Q; Liu S; Liu Y; Zheng D Cancer Immunol Immunother; 2013 Apr; 62(4):653-63. PubMed ID: 23143747 [TBL] [Abstract][Full Text] [Related]
15. Activated human mesenchymal stem/stromal cells suppress metastatic features of MDA-MB-231 cells by secreting IFN-β. Yoon N; Park MS; Shigemoto T; Peltier G; Lee RH Cell Death Dis; 2016 Apr; 7(4):e2191. PubMed ID: 27077807 [TBL] [Abstract][Full Text] [Related]
17. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells. Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708 [TBL] [Abstract][Full Text] [Related]
18. IFN-γ-primed human bone marrow mesenchymal stem cells induce tumor cell apoptosis in vitro via tumor necrosis factor-related apoptosis-inducing ligand. Du J; Zhou L; Chen X; Yan S; Ke M; Lu X; Wang Z; Yu W; Xiang AP Int J Biochem Cell Biol; 2012 Aug; 44(8):1305-14. PubMed ID: 22554587 [TBL] [Abstract][Full Text] [Related]
19. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin. Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094 [TBL] [Abstract][Full Text] [Related]
20. Suppressing orthotopic pancreatic tumor growth with a fiber-modified adenovector expressing the TRAIL gene from the human telomerase reverse transcriptase promoter. Jacob D; Davis J; Zhu H; Zhang L; Teraishi F; Wu S; Marini FC; Fang B Clin Cancer Res; 2004 May; 10(10):3535-41. PubMed ID: 15161713 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]